Oxnard, CA- FOMAT Medical Research announced today the launch of its new Phase I capabilities. The expansion will enhance FOMAT’s ability to provide efficient and high-quality services to its clients in the pharmaceutical and biotech industries.
The expanded capabilities will include the addition of new state-of-the-art facilities, specialized staff, and innovative technology. FOMAT will now offer a full range of Phase I services, including early-phase clinical trials, pharmacokinetic and pharmacodynamic studies, and first-in-human trials.
The clinic and site-specific processes are designed to carry out simple and complex clinical trials, offered across multiple therapeutic specialties, including infectious diseases, vaccines, CNS, Autoimmune, Inflammation, Metabolic, Endocrinology, NAFLD, NASH, Obesity, T2D clinical trials.
FOMAT Medical Research’s Ealy Phase/Phase One clinic is located just outside of Los Angeles, in Oxnard, California. It features state-of-the art facilities and marks a significant milestone in the company’s service offering, covering all phases of clinical development, and bolsters its ongoing commitment to innovate healthcare through diversity.
About FOMAT Medical Research
Estamos ubicados en Oxnard, California, somos una Organización de Investigación Integrada (IRO), un subgrupo de una Organización y Gestión de Centros (SMO), nos enfocamos en innovar el cuidado de la salud a través de nuestros servicios. Tenemos más de 10 años de experiencia en la participación en ensayos clínicos de fase 1 a 4 en múlltiples áreas terapéuticas, contamos con un equipo experimentado en investigación con la pericia profesional necesaria para colaborar junto a los patrocinadores y a las organizaciones de investigación por contrato (CRO) a alcanzar sus objetivos de sus proyectos con rapidez y eficacia.
Contact Information:
If you want more information about our Phase 1 capabilities, please contact: